跳至主要内容
临床试验/NCT01779596
NCT01779596已完成4 期

Effect of a Dual ET-blocker on Exercise Induced Blood Flow and Endothelial Function in T2DM

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2011年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
22
试验地点
1
主要终点
exercise induced blood flow

研究概览

简要总结

The purpose of this study is to establish the effect of ET blockade on the acute exercise induced blood flow and endothelial function in subjects with T2DM. We hypothesize that combining ET - blockade with exercise training leads to an acute increase of exercise induced blood flow when compared with exercise alone. We expect that this will lead to an optimization of vascular training effect in T2DM.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Type 2 Diabetes Mellitus (>2 years since diagnosis) OR controls

排除标准

  • <40 years of age
  • >65 years of age
  • cardiovascular disease
  • diabetes related manifest vascular complications
  • Type 1 Diabetes Mellitus
  • use of Glibenclamide
  • use of HIV drugs
  • use of calcineurin inhibitors
  • use of drugs that interfere with CYP3A4 and CYP2C19

研究组 & 干预措施

Bosentan

Experimental

Single dose of Bosentan (125 mg)

干预措施: Bosentan (Drug)

Placebo

Placebo Comparator

Single dose of placebo (125 mg)

干预措施: Placebo (Drug)

结局指标

主要结局

exercise induced blood flow

时间窗: 2 hours

次要结局

  • exercise induced Flow Mediated Dilation(2 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验